Angiogenesis in cancer - general pathways and their therapeutic implications.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7892/BORIS.83821PMID 24659637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor angiogenesis

  2020cited by this paper
• Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

  2013influential reference
• Specialized Tip/Stalk-Like and Phalanx-Like Endothelial Cells from Embryonic Stem Cells

  2013cited by this paper
• The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Context-Dependent Approaches to Notch Targeting as Cancer Therapy

  2012cited by this paper
• Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

  2011cited by this paper
• Dll4-Notch signaling as a therapeutic target in tumor angiogenesis

  2011cited by this paper
• Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

  2011cited by this paper
• Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice.

  2011cited by this paper
• Role of Notch signaling in colon homeostasis and carcinogenesis

  2011influential reference
• Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think

  2011cited by this paper
• Axon guidance molecules in vascular patterning.

  2010cited by this paper
• The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.

  2009cited by this paper
• Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

  2009cited by this paper
• Tumor angiogenesis.

  2008cited by this paper
• Activation of Notch signaling in human colon adenocarcinoma.

  2008influential reference
• Differential Notch and TGFβ Signaling in Primary Colorectal Tumors and Their Corresponding Metastases

  2008cited by this paper
• Notch signaling regulates tumor angiogenesis by diverse mechanisms

  2008cited by this paper
• Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.

  2008influential reference
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007influential reference
• The multifaceted role of Notch in cancer.

  2007cited by this paper
• Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer

  2007cited by this paper
• Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

  2007cited by this paper
• The role of neuropilins in cancer

  2006cited by this paper
• Up-Regulation of Endothelial Delta-like 4 Expression Correlates with Vessel Maturation in Bladder Cancer

  2006cited by this paper
• Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

  2006cited by this paper
• Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

  2006cited by this paper
• Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

  2005cited by this paper
• The Notch Signaling Pathway Is Related to Neurovascular Progression of Pancreatic Cancer

  2005influential reference
• Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors

  2005cited by this paper
• High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.

  2005cited by this paper
• Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

  2005cited by this paper
• The role of pericytes in blood-vessel formation and maintenance.

  2005cited by this paper
• Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43–9006) in patients with advanced renal cell carcinoma (RCC)

  2005influential reference
• Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

  2005cited by this paper
• Patient reported outcomes in a phase 2 trial of SU11248 for metastatic renal cell carcinoma

  2005cited by this paper
• Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC)

  2005cited by this paper
• A phase 2 study to evaluate the efficacy and safety of SU11248 in patients (pts) with unresectable neuroendocrine tumors (NETs)

  2005cited by this paper
• A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)

  2005influential reference
• JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence

  2004cited by this paper
• A phase I/II trial of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with either temozolomide or lomustine for patients with recurrent glioblastoma multiforme (GBM).

  2004cited by this paper
• Targeted therapy of colorectal cancer: clinical experience with bevacizumab.

  2004cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• The role of Notch in tumorigenesis: oncogene or tumour suppressor?

  2003cited by this paper
• Signal transduction to hypoxia-inducible factor 1.

  2002cited by this paper
• Notch: a membrane-bound transcription factor.

  2002cited by this paper
• Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis.

  2001cited by this paper
• Antiangiogenic agents and their promising potential in combined therapy.

  2001cited by this paper
• Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis.

  2001cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Vascular endothelial growth factor (VEGF) and its receptors

  1999cited by this paper
• Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

  1999cited by this paper
• Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• Molecular-targeted Therapy for Precision Medicine in Gastrointestinal Cancer: Advancement in Cancer Targeting Strategies.

  2025cites this paper
• Significance and mechanisms of perineural invasion in malignant tumors

  2025cites this paper
• Vascular mimicry in zebrafish fin regeneration: how macrophages build new blood vessels

  2024cites this paper
• The Pattern of Cytokines, Chemokines, and Growth Factors of the Maxillary and Mandibular Periosteum After Exposure to Titanium Fixations—Ti6Al4V

  2024cites this paper
• Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis

  2024cites this paper
• Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer

  2023cites this paper
• Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies

  2023cites this paper
• Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways

  2023cites this paper
• Narrative review on efficacy and safety of anti-angiogenesis in combination with immunotherapy in the treatment of breast cancer

  2023cites this paper
• Synthesis and in-vitro anti-proliferative with antimicrobial activity of new coumarin containing heterocycles hybrids

  2023cites this paper
• The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features

  2023cites this paper
• Immunomodulatory effect of ADO on liver tumor microenvironment

  2022cites this paper
• Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry

  2022cites this paper
• Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

  2022cites this paper
• Sulfated galactoglucan impedes xenografted lung cancer cell growth by blocking angiogenesis via binding BMPRs.

  2022cites this paper
• Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer

  2022cites this paper
• Molecular Mechanism of Metastasis in Colorectal Cancer and Organotropism

  2022cites this paper
• Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach.

  2022cites this paper
• Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer

  2022influential citation
• Inhibitory effects of terrein on lung cancer cell metastasis and angiogenesis

  2021cites this paper
• Controlled Delivery of Slit3 Proteins from Alginate Microbeads Inhibits In Vitro Angiogenesis.

  2021cites this paper
• Regulation of angiogenesis by microRNAs in cancer

  2021cites this paper
• Research Progress of Anti-Tumor Angiogenesis in Traditional Chinese Medicine

  2021cites this paper
• Molecular-targeted therapy toward precision medicine for gastrointestinal caner: Current progress and challenges

  2021cites this paper
• Anti-angiogenic effects of chemotherapeutic agents and their enhancement with OT-515 and S-NACH

  2021cites this paper
• Review and comparative analysis of machine learning-based predictors for predicting and analyzing of anti-angiogenic peptides.

  2021cites this paper
• CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma

  2020cites this paper
• Progress in Microbes and Molecular Biology

  2020cites this paper
• Multifaceted Roles of Caveolin-1 in Lung Cancer: A New Investigation Focused on Tumor Occurrence, Development and Therapy

  2020cites this paper
• Tumor-Derived EV-Encapsulated miR-181b-5p Induces Angiogenesis to Foster Tumorigenesis and Metastasis of ESCC

  2020cites this paper
• Anti-angiogenic activity of ShengMaBieJia decoction in vitro and in acute myeloid leukaemia tumour-bearing mouse models

  2020cites this paper
• Epigenetic regulation of angiogenesis in lung cancer

  2020cites this paper
• Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension.

  2020cites this paper
• The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors

  2020cites this paper
• Tumor microenvironment components: Allies of cancer progression.

  2019cites this paper
• Significance of Bone Vasculature in Health and Disease

  2019cites this paper
• Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions

  2019cites this paper
• Protocol development for discovery of angiogenesis inhibitors via automated methods using zebrafish

  2019cites this paper
• Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse

  2019cites this paper
• The Role of Natural of AntisenseTranscription HAGLR,LCMT1AS, NAV2AS5,TSIX in Breast Cancer

  2019cites this paper
• Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread

  2019cites this paper
• Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer

  2019cites this paper
• Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

  2019cites this paper
• Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets

  2019cites this paper
• Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma

  2019cites this paper
• Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization

  2019cites this paper
• Eriocalyxin B Biological Activity: A Review on Its Mechanism of Action

  2019cites this paper
• Hydroalcoholic extract of Brazilian green propolis modulates inflammatory process in mice submitted to a low protein diet.

  2019cites this paper
• FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.

  2018cites this paper
• Angiotensin II: a key mediator in the development of liver fibrosis and cancer

  2018cites this paper
• Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies

  2018cites this paper
• Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway

  2018cites this paper
• BAG3 Protein Is Involved in Endothelial Cell Response to Phenethyl Isothiocyanate

  2018cites this paper
• Effects of Enoxaparin Emulsion on Dimethylbenzanthracene-induced Breast Cancer in Female Rats

  2018cites this paper
• Tumor angiogenesis and anti-angiogenic gene therapy for cancer

  2018cites this paper
• A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway

  2018cites this paper
• Link between estrogen deficiency osteoporosis and susceptibility to bone metastases: A way towards precision medicine in cancer patients.

  2018cites this paper
• The effect of adalimumab on the vasculature in psoriatic skin lesions

  2018cites this paper
• Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis

  2018cites this paper
• A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation

  2018cites this paper
• Nanoparticles as new tools for inhibition of cancer angiogenesis

  2018cites this paper
• Troponin through the looking-glass: emerging roles beyond regulation of striated muscle contraction

  2017cites this paper
• The Multiple Roles of Exosomes in Metastasis.

  2017cites this paper
• Evaluation of the Anti-angiogenic Effect of -glucan Extracted from P. eryngii

  2017cites this paper
• Roles of long noncoding RNAs in colorectal cancer metastasis

  2017cites this paper
• Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway

  2017cites this paper
• Safety profile of temsirolimus in patients with metastatic renal cell carcinoma.

  2016cites this paper
• SHH signaling mediates the effect of PPAR β / δ on angiogenesis following cerebral ischemia

  2016cites this paper
• Targeting angiogenesis in gastrointestinal tumors: current challenges.

  2016cites this paper
• Notch signaling in cerebrovascular diseases (Review)

  2016cites this paper
• Epigenetics and Angiogenesis in Cancer

  2016cites this paper
• Progress in the research on the mechanism of bone metastasis in lung cancer

  2016cites this paper
• Growth factors and kinases in glioblastoma growth

  2016cites this paper
• Trophoblast models for tumour studies : understanding the similarities of tumour and trophoblast invasion

  2016cites this paper
• Design, Synthesis and Biological Evaluation of Potential Inhibitors of S100P, a Protein implicated in Pancreatic Cancer

  2016cites this paper
• Cytotoxic effects of the anthraquinone derivatives 1′-deoxyrhodoptilometrin and (S)-(−)-rhodoptilometrin isolated from the marine echinoderm Comanthus sp.

  2016cites this paper
• VEGF receptor subtypes may serve as novel prognostic factors and putative indicators for anti VEGF receptor treatment response in renal cell carcinoma cases.

  2016cites this paper
• Neovascularity as a prognostic marker in renal cell carcinoma.

  2016cites this paper
• Introduction Safety profile of temsirolimus in patients with metastatic renal cell carcinoma

  2016cites this paper
• “TUMOR ANGIOGENESIS- A REVIEW”

  2016cites this paper
• Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian “Real-World” SAX Study

  2016influential citation
• Construction and expression of an anti-VEGFR2 Nanobody-Fc fusionbody in NS0 host cell.

  2016cites this paper
• Investigation of injection dose and camera integration time on quantifying pharmacokinetics of a Cy5.5-GX1 probe with dynamic fluorescence imaging in vivo

  2016cites this paper
• Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system

  2016cites this paper
• Obesity and cancer phenotype: Is angiogenesis a missed link?

  2015cites this paper
• microRNA–200b as a Switch for Inducible Adult Angiogenesis

  2015cites this paper
• Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition

  2015cites this paper
• Critical role of CDK11p58 in human breast cancer growth and angiogenesis

  2015cites this paper
• Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma

  2015cites this paper
• Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice.

  2015cites this paper
• FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer.

  2015cites this paper
• New therapeutic targets for cancer bone metastasis.

  2015cites this paper
• Identification of VEGFR2-binding peptides using high throughput bacterial display methods and functional assessment.

  2015cites this paper
• Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.

  2015cites this paper
• Expression and clinical significance of microvessel density and its association with TWIST in nasopharyngeal carcinoma.

  2015cites this paper
• Gene expression characteristics of breast cancer stem cells.

  2015cites this paper
• ASC, a Bioactive Steroidal Saponin from Ophitopogin japonicas, Inhibits Angiogenesis through Interruption of Src Tyrosine Kinase‐dependent Matrix Metalloproteinase Pathway

  2015cites this paper
• Procyanidin B2 3,3″-di-O-gallate inhibits endothelial cells growth and motility by targeting VEGFR2 and integrin signaling pathways.

  2015cites this paper
• Role of the peritoneum and transforming growth factor β in the aetiology of endometriosis

  2015cites this paper
• VEGF and Notch Signaling in Angiogenesis

  2015cites this paper